BioCentury
ARTICLE | Company News

FDA wants another Saforis trial

October 13, 2006 12:47 AM UTC

MGI Pharma (MOGN) said it received an approvable letter from FDA for Saforis oral suspension to treat and prevent oral mucositis in which the agency asked for an additional Phase III trial. MOGN said ...